An Interactive Text Messaging Intervention to Improve Adherence to Option B+ Prevention of Mother-to-Child HIV Transmission in Kenya: Cost Analysis.


Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
02 10 2020
Historique:
received: 21 02 2020
accepted: 17 08 2020
revised: 06 08 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 28 4 2021
Statut: epublish

Résumé

Mobile health (mHealth) approaches offer potentially affordable ways to support the care of HIV-infected patients in overstretched health care systems. However, only few studies have analyzed the costs associated with mHealth solutions for HIV care. The aim of this study was to estimate the total incremental costs and incremental cost per beneficiary of an interactive SMS text messaging support intervention within a clinical trial. The Mobile WAChX trial (NCT02400671) evaluates an interactive semiautomated SMS text messaging intervention to improve adherence to antiretroviral therapy and retention in care among peripartum women infected with HIV in Kenya to reduce the mother-to-child transmission of HIV. Women were randomized to receive one-way versus two-way SMS text messages. Messages were sent weekly, and these messages included motivational and educational content and visit reminders; two-way messaging enabled prompt consultation with the nurse as needed. Microcosting methods were used to collect resource-use data related to implementing the Mobile WAChX SMS text messaging intervention. At 2 sites (Nairobi and Western Kenya), we conducted semistructured interviews with health personnel to identify startup and recurrent activities by obtaining information on the personnel, supplies, and equipment. Data on expenditures and prices from project expense reports, administrative records, and published government salary data were included to estimate the total incremental costs. Using a public provider perspective, we estimated incremental unit costs per beneficiary and per contact during 2017. The weighted average annual incremental costs for the two-way SMS text messaging group were US $3725 per facility, US $62 per beneficiary, and US $0.85 per contact to reach 115 beneficiaries. For the one-way SMS text messaging group, the weighted average annual incremental costs were US $2542 per facility, US $41 per beneficiary, and US $0.66 per contact to reach 117 beneficiaries. The largest cost shares were for the personnel: 48.2% (US $1794/US $3725) in two-way and 32.4% (US $825/US $2542) in one-way SMS text messaging groups. Costs associated with software development and communication accounted for 29.9% (US $1872/US $6267) of the costs in both intervention arms (US $1042 vs US $830, respectively). Cost information for budgeting and financial planning is relevant for implementing mHealth interventions in national health plans. Given the proportion of costs related to systems development, it is likely that costs per beneficiary will decline with the scale-up of the interventions.

Sections du résumé

BACKGROUND
Mobile health (mHealth) approaches offer potentially affordable ways to support the care of HIV-infected patients in overstretched health care systems. However, only few studies have analyzed the costs associated with mHealth solutions for HIV care.
OBJECTIVE
The aim of this study was to estimate the total incremental costs and incremental cost per beneficiary of an interactive SMS text messaging support intervention within a clinical trial.
METHODS
The Mobile WAChX trial (NCT02400671) evaluates an interactive semiautomated SMS text messaging intervention to improve adherence to antiretroviral therapy and retention in care among peripartum women infected with HIV in Kenya to reduce the mother-to-child transmission of HIV. Women were randomized to receive one-way versus two-way SMS text messages. Messages were sent weekly, and these messages included motivational and educational content and visit reminders; two-way messaging enabled prompt consultation with the nurse as needed. Microcosting methods were used to collect resource-use data related to implementing the Mobile WAChX SMS text messaging intervention. At 2 sites (Nairobi and Western Kenya), we conducted semistructured interviews with health personnel to identify startup and recurrent activities by obtaining information on the personnel, supplies, and equipment. Data on expenditures and prices from project expense reports, administrative records, and published government salary data were included to estimate the total incremental costs. Using a public provider perspective, we estimated incremental unit costs per beneficiary and per contact during 2017.
RESULTS
The weighted average annual incremental costs for the two-way SMS text messaging group were US $3725 per facility, US $62 per beneficiary, and US $0.85 per contact to reach 115 beneficiaries. For the one-way SMS text messaging group, the weighted average annual incremental costs were US $2542 per facility, US $41 per beneficiary, and US $0.66 per contact to reach 117 beneficiaries. The largest cost shares were for the personnel: 48.2% (US $1794/US $3725) in two-way and 32.4% (US $825/US $2542) in one-way SMS text messaging groups. Costs associated with software development and communication accounted for 29.9% (US $1872/US $6267) of the costs in both intervention arms (US $1042 vs US $830, respectively).
CONCLUSIONS
Cost information for budgeting and financial planning is relevant for implementing mHealth interventions in national health plans. Given the proportion of costs related to systems development, it is likely that costs per beneficiary will decline with the scale-up of the interventions.

Identifiants

pubmed: 33006562
pii: v8i10e18351
doi: 10.2196/18351
pmc: PMC7568211
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e18351

Subventions

Organisme : NIAID NIH HHS
ID : K01 AI116298
Pays : United States
Organisme : NICHD NIH HHS
ID : K24 HD054314
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD080460
Pays : United States

Informations de copyright

©Yilin Chen, Keshet Ronen, Daniel Matemo, Jennifer A Unger, John Kinuthia, Grace John-Stewart, Carol Levin. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 02.10.2020.

Références

JMIR Mhealth Uhealth. 2018 Jul 27;6(7):e153
pubmed: 30054263
AIDS Care. 2017 Apr;29(4):409-417
pubmed: 27477580
JMIR Mhealth Uhealth. 2018 Jan 09;6(1):e7
pubmed: 29317380
JAMA Intern Med. 2016 Mar;176(3):340-9
pubmed: 26831740
Cochrane Database Syst Rev. 2012 Mar 14;(3):CD009756
pubmed: 22419345
Cost Eff Resour Alloc. 2018 Jun 25;16:25
pubmed: 29983645
PLoS One. 2016 May 04;11(5):e0154664
pubmed: 27144393
Cost Eff Resour Alloc. 2017 Apr 17;15:5
pubmed: 28428734
Lancet HIV. 2014 Dec;1(3):e104-11
pubmed: 26424119
Am J Med. 2015 Oct;128(10):1139.e1-5
pubmed: 26087045
Lancet. 2010 Nov 27;376(9755):1838-45
pubmed: 21071074
Telemed J E Health. 2015 Feb;21(2):81-5
pubmed: 25474190
PLoS One. 2018 Jul 6;13(7):e0197305
pubmed: 29979704
Contemp Clin Trials. 2017 Jun;57:44-50
pubmed: 28315480
PLoS One. 2014 Feb 05;9(2):e88166
pubmed: 24505411
Open AIDS J. 2017 Nov 21;11:119-132
pubmed: 29290888
Telemed J E Health. 2016 Apr;22(4):317-24
pubmed: 26348994
Glob J Health Sci. 2016 Jan 21;8(9):54429
pubmed: 27157176

Auteurs

Yilin Chen (Y)

Department of Global Health, University of Washington, Seattle, WA, United States.

Keshet Ronen (K)

Department of Global Health, University of Washington, Seattle, WA, United States.

Daniel Matemo (D)

Kenyatta National Hospital, Nairobi, Kenya.

Jennifer A Unger (JA)

Department of Global Health, University of Washington, Seattle, WA, United States.

John Kinuthia (J)

Kenyatta National Hospital, Nairobi, Kenya.

Grace John-Stewart (G)

Department of Global Health, University of Washington, Seattle, WA, United States.

Carol Levin (C)

Department of Global Health, University of Washington, Seattle, WA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH